These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 3087281

  • 1. In vitro activity of BRL 36650, a new penicillin.
    Van Landuyt HW, Lambert A, Boelaert J, Gordts B.
    Antimicrob Agents Chemother; 1986 Feb; 29(2):362-6. PubMed ID: 3087281
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates.
    Fuchs PC, Jones RN, Barry AL, Ayers LW, Gavan TL, Gerlach EH.
    Diagn Microbiol Infect Dis; 1986 Nov; 5(4):345-9. PubMed ID: 3536278
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.
    Hoogkamp-Korstanje JA, Meijer CA.
    Eur J Clin Microbiol; 1982 Jun; 1(3):166-70. PubMed ID: 6293813
    [Abstract] [Full Text] [Related]

  • 4. Belgian multicentre study on the in vitro activity of cefepime against gram-negative bacilli.
    Verbist L, Glupczynski Y.
    Acta Clin Belg; 1996 Jun; 51(1):28-35. PubMed ID: 8669160
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activity of cefepime against nosocomial isolates.
    Sofianou D, Tsoulfa S, Kontodimou L, Polydorou F, Malaka E.
    J Chemother; 1997 Oct; 9(5):341-6. PubMed ID: 9373789
    [Abstract] [Full Text] [Related]

  • 6. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
    Chen YH, Peng CF, Lu PL, Tsai JJ, Chen TP.
    Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
    [Abstract] [Full Text] [Related]

  • 7. In-vitro activity of BRL-36650, a novel beta-lactamase-stable penicillin, against multiply resistant gram-negative organisms.
    Verbist L.
    J Antimicrob Chemother; 1986 Sep; 18(3):351-8. PubMed ID: 3095299
    [Abstract] [Full Text] [Related]

  • 8. In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin.
    Basker MJ, Edmondson RA, Knott SJ, Ponsford RJ, Slocombe B, White SJ.
    Antimicrob Agents Chemother; 1984 Nov; 26(5):734-40. PubMed ID: 6440479
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R, Mittermayer H, Feierl G, Allerberger F, Wendelin I, Hirschl A, Reisinger EC.
    Wien Klin Wochenschr; 1999 Jul 30; 111(14):549-54. PubMed ID: 10467641
    [Abstract] [Full Text] [Related]

  • 12. In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa.
    Oie S, Sawa A, Kamiya A, Mizuno H.
    J Antimicrob Chemother; 1999 Nov 30; 44(5):689-91. PubMed ID: 10552987
    [Abstract] [Full Text] [Related]

  • 13. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN, Barry AL, Thornsberry C, Gerlach EH, Fuchs PC, Gavan TL, Sommers HM.
    J Antimicrob Chemother; 1981 Sep 30; 8 Suppl B():187-211. PubMed ID: 19802985
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL, Lewis RP, Meyer RD.
    Antimicrob Agents Chemother; 1978 Mar 30; 13(3):484-9. PubMed ID: 122524
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa.
    Heym B, Lacroix O, Péan Y, Gertner J, Nicolas MH, Jarlier V.
    J Antimicrob Chemother; 1994 Apr 30; 33(4):729-35. PubMed ID: 8056691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.